The vesicular soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) tetanus neurotoxin-insensitive vesicle-associated membrane protein (TI-VAMP/VAMP7) was previously shown to mediate an exocytic pathway involved in neurite growth, but its regulation is still largely unknown. Here we show that TI-VAMP interacts with the Vps9 domain and ankyrin-repeat-containing protein (Varp), a guanine nucleotide exchange factor (GEF) of the small GTPase Rab21, through a specific domain herein called the interacting domain (ID). Varp, TI-VAMP and Rab21 co-localize in the perinuclear region of differentiating hippocampal neurons and transiently in transport vesicles in the shaft of neurites. Silencing the expression of Varp by RNA interference or expressing ID or a form of Varp deprived of its Vps9 domain impairs neurite growth. Furthermore, the mutant form of Rab21, defective in GTP hydrolysis, enhances neurite growth. We conclude that Varp is a positive regulator of neurite growth through both its GEF activity and its interaction with TI-VAMP.
INTRODUCTION
The vesicular exocytic traffic is an essential mechanism to sustain membrane expansion in several processes in eukaryotic cells, including neurite growth (Futerman & Banker, 1996; Pfenninger, 2009) . It is widely accepted that the general mechanisms underlying membrane traffic can be divided into four essential steps-that include vesicle budding, transport, tethering and fusion (Bonifacino & Glick, 2004 )-and are regulated by Rab GTPases (Zerial & McBride, 2001; Grosshans et al, 2006) and soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) proteins (Jahn & Scheller, 2006) . Although much is known about the functions of Rabs and SNAREs in these processes, so far only a few members of these two families have been shown to have documented roles in neurite growth (Ng & Tang, 2008) . The tetanus neurotoxin insensitive vesicle-associated membrane protein (TI-VAMP/VAMP7) is a vesicular SNARE (v-SNARE) that mediates an exocytic pathway that is crucial for neurite growth in PC12 cells and in neurons in primary culture (Martinez-Arca et al, 2000 , 2001 Alberts et al, 2003) . In yeast two-hybrid screens, we identified the Vps9 domain and ankyrinrepeat-containing protein (Varp) as a new partner for TI-VAMP. Varp was recently shown to be a guanine nucleotide exchange factor (GEF) for Rab21 (Zhang et al, 2006) , a small GTPase that regulates phagocytosis (Khurana et al, 2005) , cell adhesion, cell migration and cytokinesis by controlling the endosomal trafficking of b1-integrins (Pellinen et al, 2006 (Pellinen et al, , 2008 . These findings prompted us to study the biological meaning of the interaction between Varp and TI-VAMP and to characterize the function of Varp and Rab21 in neurite growth. Our results show that, similarly to TI-VAMP, Varp and Rab21 are positive regulators of neurite growth.
RESULTS

The GEF Rab21 Varp is a new TI-VAMP-interacting protein
To identify the partners of TI-VAMP, we carried out a yeast twohybrid screen using the full cytoplasmic domain of TI-VAMP as bait in a human placental library. Among already characterized partners of TI-VAMP, such as syntaxin 3, SNAP23, AP-3d and HRB (Martinez-Arca et al, 2003; Scheuber et al, 2006; Chaineau et al, 2008) , this screen identified Varp as a new TI-VAMP-interacting protein. The screen was repeated using a human fetal brain library and produced similar results. The region from amino acids 641 to 707 was present in all clones corresponding to Varp isolated in both yeast two-hybrid screens, defining the probable minimal domain responsible for the interaction with TI-VAMP (Fig 1A) , herein called the interacting domain (ID). To gain insight into the TI-VAMP-Varp interaction, we generated a Varp antibody directed against ID (supplementary Fig S1A online) and confirmed the interaction using in vitro biochemical assays (Fig 1B) . In glutathione-S-transferase (GST) pull-down experiments, Varp interacted with the full-length TI-VAMP, its amino-terminal domain (Longin), and the protein with this domain deleted (DLongin) corresponding to the SNARE domain, suggesting that Varp has two binding sites in TI-VAMP. Furthermore, TI-VAMP co-precipitated green fluorescent protein (GFP)-tagged ID and Varp from HeLa cells (Fig 1C) and endogenous Varp from PC12 cells (Fig 1D) , further confirming the interaction in vivo. The N-terminal region of Varp includes a Vps9 domain that has recently been shown to have Rab21 GEF activity (Zhang et al, 2006) . Using a wild-type (wt) myc-tagged Rab21 form or locked either in the GDP-bound (T33N) or GTP-bound (Q78L) state, we showed that endogenous Varp precipitated with Rab21, preferentially with Rab21-T33N (supplementary Fig S1B online) as expected for a GEF (Boguski & McCormick, 1993; Delprato & Lambright, 2007) . It has been shown that Rab21-T33N concentrates in the trans-Golgi network (TGN; Simpson et al, 2004 ; and data not shown), thus interaction between Rab21 and Varp is likely to occur in the TGN. We studied the localization of untagged and GFP-tagged Varp in cells moderately overexpressing the proteins to bypass the weak staining produced by immunohistochemistry using Varp antibody. As shown in Fig 2A, Varp strongly localized with TI-VAMP mainly in the perinuclear region of HeLa cells. Both proteins co-localized in vesicles, often in close proximity to microtubules (Fig 2A, Merge) , suggesting a potential role of Varp in the transport of TI-VAMP. Using live-cell imaging, we observed that Varp-GFP and red fluorescent protein (RFP)-TI-VAMP were partially transported in the same vesicles in mouse hippocampal neurons in culture both under control conditions and in Brefeldin A washout experiments (Jareb & Banker, 1997) , suggesting that this interaction might be related to transport from the cell body into growing neurites (Fig 2B; supplementary Movies S1 and S2 online). To gain insight into the potential TI-VAMP-Varp-Rab21 connection, we analysed their distribution in PC12 cells and in mouse hippocampal neurons in culture. Rab21, Varp and TI-VAMP largely co-localized in the perinuclear region and partially along the neurites, both in mouse hippocampal neurons ( Fig 2C) and in differentiated PC12 cells (supplementary Fig S2 online) . The peripheral region of the growth cone was largely devoid of Varp and Rab21, whereas TI-VAMP was present and dynamic in filopodia (Fig 2D,E (Fig 3C-F) , further establishing the role of Varp in neurite and axon growths. As GFP-ID interacts with TI-VAMP in vivo (Fig 1C) , it was reasonable to think that the expression of ID might inhibit axonal growth by preventing the formation of the endogenous TI-VAMP-Varp complex. We thus expressed Varp-GFP and GFP-ID, GFP alone being our control, in developing mouse hippocampal neurons. We found that GFP-ID inhibited axonal growth (Fig 3G-I ). We also tested the effect of a mutant of Varp lacking the Vps9 domain (DVps9-Varp-GFP) because this domain has been shown to be responsible for the GEF activity of Varp (Zhang et al, 2006) . This truncated protein, which includes ID, still interacted with TI-VAMP (supplementary Fig S3C online) and had a dominantnegative effect on neurite growth (supplementary Fig S3 online) . We conclude that the interaction of Varp with TI-VAMP and its GEF activity have an important function in neurite growth.
Varp is required for TI-VAMP-Rab21 co-localization
The inactivated form of Rab21, Rab21-T33N, has previously been shown to concentrate in TGN (Simpson et al, 2004) and TI-VAMP has been shown to regulate the exocytosis of post-Golgi vesicles (Alberts et al, 2006; Scheuber et al, 2006; Sander et al, 2008) . TI-VAMP and Rab21 co-localized to a significant extent in the perinuclear region of HeLa (Fig 4A) , PC12 cells (supplementary Fig S2 online ) and hippocampal neurons (Fig 2C) , suggesting a conserved mechanism of sorting. As TGN is an important site for protein sorting in the exocytic pathway, we analysed the staining of TI-VAMP, Rab21 and the marker TGN46. We saw partial and significant co-localization in HeLa cells (Fig 4A; supplementary Fig S4 online Fig 4A, left panels) , whereas this co-localization was reduced in Varp siRNA-treated cells (Fig 4A, right panels) . A statistical analysis confirmed the reduction of co-localization between TI-VAMP and Rab21 in Varp siRNA-treated cells (Fig 4C,D) . Therefore, despite the lack of evidence for a tripartite complex (data not shown), the Rab21 GEF Varp might establish a functional link between TI-VAMP and Rab21, probably occurring at TGN sites.
Rab21 regulates neurite growth
As TI-VAMP and Varp are both involved in neurite growth, and the Vps9 domain of Varp is required for this function, we then investigated the role of Rab21, studying the effect of the expression of constitutively active and inactive mutants of Rab21 on neurite growth in PC12 cells. As shown in Fig 5A, B, Rab21-Q78 L significantly stimulated the growth of long neurites. By contrast, Rab21-T33N had no effect on the growth of neurites longer than 40 mm (Fig 5B) We did not see a significant effect on the average neurite length in Rab21-silenced PC12 cells and mouse hippocampal neurons (data not shown). A likely explanation might be that other isoforms of Rab21-or other closely related Rab proteins-are able to compensate for the lack of Rab21, as in the cases of Rab3 (Schluter et al, 2004) and Rab32/38 (Wasmeier et al, 2006) .
DISCUSSION
Here we show that Varp is a positive regulator of neurite growth and particularly of axonal growth in hippocampal neurons. Varp is able to interact with TI-VAMP, and expressing ID strongly impairs neurite growth. Furthermore, Varp activates Rab21 through its Vps9 domain, and a form of Varp lacking this domain inhibits neurite growth. Silencing the expression of Varp also inhibits neurite growth. Altogether these data suggest that Varp is required for neurite growth and that both Vps9 domain and ID are important for its function. Our demonstration of a positive function of Varp and Rab21 in neuritogenesis, distinct from the negative roles of Rab5 and Rab11, is an important step towards a precise characterization of the function of these highly homologous Rab proteins. Indeed, it has been recently proposed that nerve-growth-factor-mediated neuritogenesis requires the downregulation of Rab5 by RabGAP5, a Rab5 GTPase-activating protein that interacts with the nerve growth factor receptor TrkA (Liu et al, 2007) . Structural studies further support the idea that Rab5 and Rab21 are likely to have different effectors (Delprato & Lambright, 2007) . In addition, protrudin is required for neurite growth and operates through interaction with the GDP-bound form of Rab11 (Shirane & Nakayama, 2006) . The characterization of the upstream signalling pathways that control Varp and the downstream effectors of Rab21 is now crucial to understand how Varp, Rab21 and TI-VAMP/VAMP7 in neurite growth A. Burgo et al likely to be more complicated than activating Rab21 and regulating TI-VAMP function. Indeed, Varp contains several ankyrin repeats (Mosavi et al, 2004) . Thus, Varp is likely to interact with yet more proteins through these domains. Furthermore, Varp has also been shown to be an effector of Rab32/38, this interaction being mediated by the first ankyrin repeat (Wang et al, 2008; Tamura et al, 2009) . This is reminiscent of the function of Sec2 in yeast, a GEF of Sec4; the targeting of Sec4 to secretory vesicles Varp, Rab21 and TI-VAMP/VAMP7 in neurite growth A. Burgo et al is regulated by Ypt32, another Rab (Ortiz et al, 2002) . In this context, Varp might seem to be an important molecular adaptor, functionally connecting and/or activating several proteins involved in different important processes that require vesicular trafficking, including neurite growth. Thus, we anticipate that Varp is likely to regulate other functions mediated by TI-VAMPdependent membrane trafficking routes (Proux-Gillardeaux et al, 2005) . Future studies will therefore be required to characterize the molecular functions of Varp, particularly how the activation by Rab32/38, the activation of Rab21 and binding to TI-VAMP are regulated in time and space.
METHODS
Cell culture and complementary DNA transfection. HeLa and L-929 cells were grown in Dulbecco 0 s modified Eagle medium (Invitrogen, Cergy Pontoise, France) supplemented with 10% fetal calf serum. PC12 cells were grown in RPMI (Roswell Park Memorial Institute) medium (Invitrogen) with 10% horse serum and 5% fetal calf serum. Hippocampal neurons were prepared from newborn P0 mice and grown on poly-Lysine-coated coverslips in Neurobasal medium supplemented with 2% B27 and 2 mM glutamine. HeLa, PC12 and hippocampal neurons at 1 day in vitro (DIV) were transfected with LipofectAMINE 2000 (Invitrogen) according to the manufacturer's instructions. siRNA knockdown. Varp, Syb2 and TI-VAMP RNA interference were achieved by using specific pre-designed siRNA duplexes (see supplementary information online for details). For every experiment carried out, non-targeting siRNAs and mock transfection were used as controls. Human HeLa cells and mouse L-929 cells were transfected once with oligonucleotides by using oligofectAMINE (Invitrogen) according to the manufacturer's instructions and cultured for a further 72-96 h. PC12 cells were transfected by using AMAXA Nucleofector TM technology (Amaxa, Köln, Germany) twice on two consecutive days. At 48 h after the second transfection, cells were differentiated with staurosporine at 37 1C, fixed and processed for analysis. Mouse hippocampal neurons were co-transfected at DIV1 with oligonucleotides and enhanced GFP by using lipofectAMINE 2000, according to the manufacturer's instructions, and cultured for an additional 72 h before being processed for immunofluorescence. 
